H2-antagonists in the treatment of colon and breast cancer
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 10 (1) , 3-10
- https://doi.org/10.1006/scbi.2000.0301
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?British Journal of Cancer, 2000
- Pilot study?cimetidine enhances lymphocyte infiltration of human colorectal carcinomaCancer, 1997
- Short-course cimetidine and survival with colorectal cancerThe Lancet, 1994
- CIMETIDINE PRESERVES NON‐SPECIFIC IMMUNE FUNCTION AFTER COLONIC RESECTION FOR CANCERAnz Journal of Surgery, 1994
- Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.Gut, 1994
- Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine)European Journal of Cancer and Clinical Oncology, 1988
- Histamine modulates the production of interferon-γ and interleukin-2 by mitogen-activated human mononuclear blood cellsCellular Immunology, 1985
- Decreased blood histamine levels in patients with solid malignant tumoursBritish Journal of Cancer, 1983
- Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: Influence of H1 and H2 histamine receptorsBritish Journal of Cancer, 1982
- Increased tissue histamine in tumour-bearing mice and ratsBritish Journal of Cancer, 1981